Abatacept: A new drug for rheumatoid arthritis treatment

content provided by mayoclinic.com

Abatacept: A new drug for rheumatoid arthritis treatment

Abatacept (Orencia) is a new drug for rheumatoid arthritis treatment.

A new class of drugs called costimulation modulators may offer hope for people with rheumatoid arthritis who haven't found relief from other drugs. The Food and Drug Administration approved abatacept (Orencia) in late 2005 for people with moderate to severe rheumatoid arthritis. Weigh the benefits and risks of abatacept if you're considering this treatment.

What triggers a toy recall?

In the United States, toy manufacturers are required to report any significant safety concerns to the Consumer Product Safety Commission (CPSC) — such as small parts that can be dislodged and pose a choking hazard or the use of paint containing lead. In turn, the CPSC may issue toy recalls as needed. Recent toy recalls have focused on toys imported from China that don't meet U.S. safety requirements.

How can I tell if my child has been exposed to too much lead?

Lead poisoning can be tough to detect. Even children who appear healthy can have elevated levels of lead in their blood. As the severity of lead poisoning increases, you might notice vague warning signs, such as irritability, weight loss and sluggishness. Your child might complain of abdominal pain, vomiting and constipation. If the level of lead continues to increase, learning difficulties or behavioral problems might become an issue.

Lead poisoning is diagnosed with a simple blood test. Again, if you're concerned about lead poisoning, ask your child's doctor about testing.

Last Updated: 04/20/2006
© 1998-2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "Mayo Clinic Health Information," "Reliable information for a healthier life" and the triple-shield Mayo logo are trademarks of Mayo Foundation for Medical Education and Research.

Terms and conditions of use


Bookmark and Share   E-Mail Page   Printer Friendly Version